Bli medlem
Bli medlem

Du är här


New US patent approval for Episurf Medical

Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled "Determination and visualization of damage to an anatomical joint", relates to 3D-based assessment of joint lesions, and complements Episurf Medical's earlier US patents within this field.

"This patent gives us additional protection in the US within medical imaging, surgical pre-planning and personalised design of implants and surgical instruments" comments Katarina Flodström, COO, Episurf Medical.  

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69

Författare Cision